Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded
- Contract number
- SPE2DB25FEJBG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,129
Award facts
- Contract value 100% obligated
- $22,129.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,129.38 to AmerisourceBergen Drug Corp for Entyvio 108 mg/0.68 mL pens on September 25, 2025, with completion scheduled for October 17, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $1 billion through December 2026.
Entyvio, a specialty pharmaceutical used primarily for treating inflammatory bowel diseases, represents the type of critical specialty medication that AmerisourceBergen supplies to support military and federal healthcare systems. The contract exemplifies AmerisourceBergen's role as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through the DLA's Medical Supply Chain. As a child contract under the larger SPE2DX vehicle, this delivery order demonstrates the flexibility and breadth of AmerisourceBergen's pharmaceutical capabilities across multiple therapeutic domains to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FEJBG?
SPE2DB25FEJBG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FEJBG worth?
The government has obligated $22,129 on SPE2DB25FEJBG.
Is contract SPE2DB25FEJBG an order under another contract?
Yes. SPE2DB25FEJBG is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEJBG competed?
The extent of competition for SPE2DB25FEJBG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award